JNJames S. Nowick

James S. Nowick

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


James S. Nowick has a total of 247 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cyclic β-sheet peptides

    by Jovanna I Carrera Plancarte, James S Nowick

  • Open Access

    Antibodies raised against a structurally defined Aβ oligomer mimic protect human iPSC neurons from Aβ toxicity at sub-stoichiometric concentrations

    by Sarah M. Ruttenberg, Rakia Dhaoui, Adam G. Kreutzer, James S. Nowick

    Anti-Aβ antibodies are important tools for identifying structural features of aggregates of the Aβ peptide and are used in many aspects of Alzheimer’s disease (AD) research. Our laboratory recently reported the generation of a polyclonal antibody, pAb2AT-L, that is moderately selective for oligomeric Aβ over monomeric and fibrillar Aβ and recognizes the diffuse peripheries of Aβ plaques in AD brain tissue but does not recognize the dense fibrillar plaque cores. This antibody was generated against 2AT-L, a structurally defined Aβ oligomer mimic composed of three Aβ-derived β-hairpins arranged in a triangular fashion and covalently stabilized with three disulfide bonds. In the current study, we set out to determine if pAb2AT-L is neuroprotective against toxic aggregates of Aβ and found that pAb2AT-L protects human iPSC-derived neurons from Aβ42-mediated toxicity at molar ratios as low as 1:100 antibody to Aβ42, with a ratio of 1:25 almost completely rescuing cell viability. Few other antibodies have been reported to exhibit neuroprotective effects at such low ratios of antibody to Aβ. ThT and TEM studies indicate that pAb2AT-L delays but does not completely inhibit Aβ42 fibrillization at sub-stoichiometric ratios. The ability of pAb2AT-L to inhibit Aβ42 toxicity and aggregation at sub-stoichiometric ratios suggests that pAb2AT-L binds toxic Aβ42 oligomers and does not simply sequester monomeric Aβ42. These results further suggest that toxic oligomers of Aβ42 share significant structural similarities with 2AT-L.


  • Open Access

    Using solution-phase NMR spectroscopy to study the folding and supramolecular assembly of conformationally constrained β-sheet peptides

    by Jason Zhu, James Nowick

    Conformationally constrained β-sheet peptides are a valuable model system for studying the folding and supramolecular assembly of aggregation-prone peptides. Understanding how these peptides assemble into soluble oligomers is central to understanding the molecular assembly of amyloid diseases. This chapter describes how to study the folding and supramolecular assembly of β-sheet peptides by solution-phase NMR spectroscopy. First, the chapter describes how to prepare an NMR sample and acquire NMR data. Then, the chapter describes how to assign residues and identify spectroscopic hallmarks of -sheet folding. Next, the chapter describes how to use isotopic labeling to verify key intermolecular contact. The chapter concludes with the spectroscopic hallmarks of supramolecular assembly. This chapter focuses on the -sheet peptides but can be generalized to the studying the folding and supramolecular assembly of a wide variety of peptides.

  • Open Access

    Antibodies raised against a structurally defined Aβ oligomer mimic protect human iPSC neurons from Aβ toxicity at sub-stoichiometric concentrations

    by Sarah M. Ruttenberg, Rakia Dhaoui, Adam G. Kreutzer, James S. Nowick

    Anti-Aβ antibodies are important tools for identifying structural features of aggregates of the Aβ peptide and are used in many aspects of Alzheimer’s disease (AD) research. Our laboratory recently reported the generation of a polyclonal antibody, pAb 2AT-L , that is moderately selective for oligomeric Aβ over monomeric and fibrillar Aβ and recognizes the diffuse peripheries of Aβ plaques in AD brain tissue but does not recognize the dense fibrillar plaque cores. This antibody was generated against 2AT-L, a structurally defined Aβ oligomer mimic composed of three Aβ-derived β-hairpins arranged in a triangular fashion and covalently stabilized with three disulfide bonds. In the current study, we set out to determine if pAb 2AT-L is neuroprotective against toxic aggregates of Aβ and found that pAb 2AT-L protects human iPSC-derived neurons from Aβ 42 -mediated toxicity at molar ratios as low as 1:100 antibody to Aβ 42 , with a ratio of 1:25 almost completely rescuing cell viability. Few other antibodies have been reported to exhibit neuroprotective effects at such low ratios of antibody to Aβ. ThT and TEM studies indicate that pAb 2AT-L delays but does not completely inhibit Aβ 42 fibrillization at sub-stoichiometric ratios. The ability of pAb 2AT-L to inhibit Aβ 42 toxicity and aggregation at sub-stoichiometric ratios suggests that pAb 2AT-L binds toxic Aβ 42 oligomers and does not simply sequester monomeric Aβ 42 . These results further suggest that toxic oligomers of Aβ 42 share significant structural similarities with 2AT-L. TOC Graphic:

  • A β-hairpin peptide derived from Aβ forms different oligomers in the crystal state and in aqueous solution

    by Jason Zhu, Adam G. Kreutzer, Zhiwei Liu, Xingyue Li, Sabrina M. Richter, Vojislava Pophristic, James S. Nowick

    The supramolecular assembly of amyloid-β into soluble oligomers is critical Alzheimer's disease (AD) progression. Soluble Aβ oligomers have emerged as neurotoxic species involved in AD progression and some Aβ oligomers are thought to be composed of β-hairpins. In this work, we report the X-ray crystallographic and solution-phase assembly of a macrocyclic β-hairpin peptide that mimics a β-hairpin formed by Aβ16–36. In the crystal lattice, the peptide assembles into a symmetric hexamer composed of two identical triangular trimers. In aqueous solution, the peptide assembles to form an asymmetric hexamer. 1H NMR, TOCSY, and 1H,15N HSQC experiments establish that the asymmetric hexamer contains two different species, A and B. 15N-edited NOESY reveals that species A is a cylindrin-like trimer and species B is a triangular trimer that collectively constitute the asymmetric hexamer. Diffusion-ordered NMR spectroscopy (DOSY) suggests that two asymmetric hexamers further assemble to form a dodecamer. NMR-guided molecular mechanics and molecular dynamics studies provide a model for the asymmetric hexamer and suggest how two asymmetric hexamers can form a dodecamer. Solution-phase NMR studies of analogues show that intermolecular hydrogen bonding and the formation of a hydrophobic core help stabilize the asymmetric hexamer. These NMR and crystallographic studies illustrate how an Aβ β-hairpin peptide can assemble to form different well-defined oligomers in the crystal state and in aqueous solution, providing a deeper understanding of the heterogeneity of Aβ oligomers and new structural models of Aβ oligomers composed of Aβ β-hairpins.


  • Open Access

    Vancomycin–Teixobactin Conjugates

    by Maria Sophia Teresa Lee Padilla, James S. Nowick

    Vancomycin continues to be a widely used antibiotic of last resort in treating drug-resistant pathogens despite the emergence of vancomycin-resistant strains such as vancomycin-resistant Enterococci (VRE). This communication reports that conjugation of vancomycin to a second antibiotic that targets a different region of lipid II enhances and rescues its antibiotic activity. Conjugation of vancomycin to a minimal teixobactin pharmacophore in which residues 1-6 are replaced with an aromatic amide results in substantial enhancement in activity over the individual components or mixtures thereof. Three conjugates with minimum inhibitory concentrations (MICs) of 0.5 μg/mL against methicillin-resistant Staphylococcus aureus (MRSA) and 0.063-0.125 μg/mL against methicillin-susceptible Staphylococcus aureus (MSSA) were identified. Each of these conjugates is also active against VRE, even though the individual components are inactive, with the most active conjugate (Cbp-Lys10-teixo7-11-vanco) having an MIC of 2-4 μg/mL. These findings demonstrate that conjugation of vancomycin to a minimal teixobactin pharmacophore is an effective strategy for enhancing the activity of vancomycin against important Gram-positive pathogens.


  • Open Access

    Potent Analogues of Clovibactin from Commercially Available Amino Acid Building Blocks

    by Jackson E. H. Brunicardi, Jeramiah J. Small, Maria Sophia Teresa Lee Padilla, Jovanna I. Carrera Plancarte, James S. Nowick

    This paper reports highly active analogues of clovibactin in which the rare, noncanonical amino acid d-hydroxyasparagine is replaced with the commercially available amino acid d-threonine. Sequential mutation of leucines 2, 7, and 8 to the more hydrophobic homologue cyclohexylalanine dramatically increases the antibiotic activity of d-Thr5-clovibactin. The resulting analogues (d-Cha2,d-Thr5-clovibactin, Cha7,d-Thr5-clovibactin, and Cha8,d-Thr5-clovibactin) are readily prepared by standard peptide synthesis techniques and exhibit excellent activity (≤1 μg/mL) against the Gram-positive, drug-resistant pathogens MRSA and VRE.


  • Open Access

    Potent Analogues of Clovibactin from Commercially Available Amino Acid Building Blocks

    by Jackson Brunicardi, Jeramiah Small, Maria Sophia Teresa Lee Padilla, Jovanna Carrera Plancarte, James Nowick

    This paper reports highly active analogues of clovibactin in which the rare, non-canonical amino acid D-hydroxyasparagine is replaced with the commercially available amino acid D-threonine. Sequential mutation of leucines 2, 7, and 8 to the more hydrophobic homologue cyclohexylalanine dramatically increases the antibiotic activity of D-Thr5-clovibactin. The resulting analogues (D-Cha2,D-Thr5-clovibactin, Cha7,D-Thr5-clovibactin, and Cha8,D-Thr5-clovibactin) are readily prepared by standard peptide synthesis techniques and exhibit excellent activity (≤ 1 μg/mL) against the Gram-positive, drug-resistant pathogens MRSA and VRE.


  • Open Access

    α-Methylation Enables the X-ray Crystallographic Observation of Oligomeric Assemblies Formed by a β-Hairpin Peptide Derived from Aβ

    by Tuan D. Samdin, Adam G. Kreutzer, Victoria Sahrai, Michał Wierzbicki, James S. Nowick

    The assembly of the β-amyloid peptide Aβ into toxic oligomers plays a significant role in the neurodegeneration associated with the pathogenesis of Alzheimer's disease. Our laboratory has developed N-methylation as a tool to enable X-ray crystallographic studies of oligomers formed by macrocyclic β-hairpin peptides derived from Aβ. In this investigation, we set out to determine whether α-methylation could be used as an alternative to N-methylation in studying the oligomerization of a β-hairpin peptide derived from Aβ. α-Methylation permits the crystallographic assembly of a triangular trimer and ball-shaped dodecamer, resembling assemblies formed by the N-methylated homolog. Subtle differences are observed in the conformation of the α-methylated peptide when compared to the N-methylated homolog. Notably, α-methylation appears to promote a flatter and more extended β-sheet conformation than that of N-methylated β-sheets or a typical unmodified β-sheet. α-Methylation provides an alternative to N-methylation in X-ray crystallographic studies of oligomers formed by peptides derived from Aβ, with the attractive feature of preserving NH hydrogen-bond donors along the peptide backbone.